Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, PK, and PD of BI 11634 in Healthy Male Volunteers
NCT02214940Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2007
- Primary completion
- Sep 2007
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of BI 11634 in thrombosis, sponsored by Boehringer Ingelheim. Primary endpoints: Number of subjects with adverse events, Number of subjects with clinically significant findings in vital signs and 3 more. Started Jun 2007; status: completed.
02
Drugs
BI 11634
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT02214940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02214940.